-transparent.png){kind=logo}
Mucosal mast cells (MMC) were isolated from the intestine of Nippostrongylus brasiliensis-infected rats and then activated with Ag or with anti-IgE in order to assess their metabolism of arachidonic acid to leukotriene (LT) C4, LTB4, and prostaglandin D2 (PGD2). After challenge of MMC preparations of 19 +/- 1% purity with five worm equivalents of N. brasiliensis Ag, the net formation of immunoreactive equivalents of LTC4, LTB4, and PGD2 was 58 +/- 8.3, 22 +/- 4.5, and 22 +/- 3.4 ng/10(6) mast cells, respectively (mean +/- SE, n = 7). When MMC preparations of 56 +/- 9% purity were activated by Ag, the net generation of immunoreactive equivalents of LTC4, LTB4, and PGD2/10(6) MMC was 107 +/- 15, 17 +/- 5.4, and 35 +/- 18 ng, respectively. These data indicate that the three eicosanoids originated from the MMC rather than from a contaminating cell. Analysis by reverse phase HPLC of the C-6 sulfidopeptide leukotrienes present in the supernatants of the activated MMC preparations of lower purity revealed LTC4, LTD4, and LTE4. In a higher purity MMC preparation only LTC4 was present, suggesting that other cell types in the mucosa are able to metabolize LTC4 to LTD4 and LTE4. The release of histamine and the generation of eicosanoids from intestinal MMC and from peritoneal cavity-derived connective tissue-type mast cells (CTMC) isolated from the same N. brasiliensis-infected rats were compared. When challenged with anti-IgE, these MMC released 165 +/- 41 ng of histamine/10(6) mast cells, and generated 29 +/- 3.6, 12 +/- 4.2, and 4.7 +/- 1.0 ng (mean +/- SE, n = 3) of immunoreactive equivalents of LTC4, LTB4, and PGD2/10(6) mast cells, respectively. In contrast, CTMC isolated from the same animals and activated with the same dose of anti-IgE released approximately 35 times more histamine (5700 +/- 650 ng/10(6) CTMC), generated 7.5 +/- 2.3 ng of PGD2/10(6) mast cells, and failed to release LTC4 or LTB4. These studies establish, that upon immunologic activation, rat MMC and CTMC differ in their quantitative release of histamine and in their metabolism of arachidonic acid to LTC4 and LTB4.
D J Heavey, and
P B Ernst, and
R L Stevens, and
A D Befus, and
J Bienenstock, and
K F Austen
January 1994,
Digestion,
D J Heavey, and
P B Ernst, and
R L Stevens, and
A D Befus, and
J Bienenstock, and
K F Austen
November 1995,
Prostaglandins, leukotrienes, and essential fatty acids,
D J Heavey, and
P B Ernst, and
R L Stevens, and
A D Befus, and
J Bienenstock, and
K F Austen
April 2001,
Inflammation research : official journal of the European Histamine Research Society ... [et al.],
D J Heavey, and
P B Ernst, and
R L Stevens, and
A D Befus, and
J Bienenstock, and
K F Austen
November 1987,
Journal of immunology (Baltimore, Md. : 1950),
D J Heavey, and
P B Ernst, and
R L Stevens, and
A D Befus, and
J Bienenstock, and
K F Austen
April 2004,
European journal of pharmacology,
D J Heavey, and
P B Ernst, and
R L Stevens, and
A D Befus, and
J Bienenstock, and
K F Austen
June 2008,
The Journal of biological chemistry,
D J Heavey, and
P B Ernst, and
R L Stevens, and
A D Befus, and
J Bienenstock, and
K F Austen
January 1981,
Kroc Foundation series,
D J Heavey, and
P B Ernst, and
R L Stevens, and
A D Befus, and
J Bienenstock, and
K F Austen
December 2006,
Allergy,
D J Heavey, and
P B Ernst, and
R L Stevens, and
A D Befus, and
J Bienenstock, and
K F Austen
January 1993,
Biology of the neonate,
D J Heavey, and
P B Ernst, and
R L Stevens, and
A D Befus, and
J Bienenstock, and
K F Austen
December 1993,
The American journal of physiology,
